Literature DB >> 16365048

Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability.

Chin-Tong Ong1, Hui-Teng Cheng, Li-Wei Chang, Toshiyuki Ohtsuka, Ryoichiro Kageyama, Gary D Stormo, Raphael Kopan.   

Abstract

All four mammalian Notch proteins interact with a single DNA-binding protein (RBP-jkappa), yet they are not equivalent in activating target genes. Parallel assays of three Notch-responsive promoters in several cell lines revealed that relative activation strength is dependent on protein module and promoter context more than the cellular context. Each Notch protein reads binding site orientation and distribution on the promoter differently; Notch1 performs extremely well on paired sites, and Notch3 prefers single sites in conjunction with a proximal zinc finger transcription factor. Although head-head sites can elicit a Notch response on their own, use of CBS (CSL binding site) in tail-tail orientation is context-dependent. Bias for specific DNA elements is achieved by interplay between the N-terminal RAM (RBP-jkappa-associated molecule/ankyrin region), which interprets CBS proximity and orientation, and the C-terminal transactivation domain that interacts specifically with the transcription machinery or nearby factors. To confirm the prediction that modular design underscores the evolution of functional divergence between Notch proteins, we generated a synthetic Notch protein (Notch1 ankyrin with Notch3 transactivation domain) that displayed superior signaling strength on the hes5 promoter. Consistent with the prediction that "preferred" targets (Hes1) should respond faster and at lower Notch concentration than other targets, we showed that Hes5-GFP was extinguished fast and recovered slowly, whereas Hes1-GFP was inhibited late and recovered quickly after a pulse of DAPT in metanephroi cultures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365048     DOI: 10.1074/jbc.M506108200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  113 in total

1.  Brain endothelial cells induce astrocytic expression of the glutamate transporter GLT-1 by a Notch-dependent mechanism.

Authors:  Meredith L Lee; Zila Martinez-Lozada; Elizabeth N Krizman; Michael B Robinson
Journal:  J Neurochem       Date:  2017-09-05       Impact factor: 5.372

2.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.

Authors:  Kelli L VanDussen; Alexis J Carulli; Theresa M Keeley; Sanjeevkumar R Patel; Brent J Puthoff; Scott T Magness; Ivy T Tran; Ivan Maillard; Christian Siebel; Åsa Kolterud; Ann S Grosse; Deborah L Gumucio; Stephen A Ernst; Yu-Hwai Tsai; Peter J Dempsey; Linda C Samuelson
Journal:  Development       Date:  2011-12-21       Impact factor: 6.868

3.  Eomesodermin induces Mesp1 expression and cardiac differentiation from embryonic stem cells in the absence of Activin.

Authors:  Jelle van den Ameele; Luca Tiberi; Antoine Bondue; Catherine Paulissen; Adèle Herpoel; Michelina Iacovino; Michael Kyba; Cédric Blanpain; Pierre Vanderhaeghen
Journal:  EMBO Rep       Date:  2012-04       Impact factor: 8.807

4.  Differential regulation of transcription through distinct Suppressor of Hairless DNA binding site architectures during Notch signaling in proneural clusters.

Authors:  John W Cave; Li Xia; Michael Caudy
Journal:  Mol Cell Biol       Date:  2010-11-01       Impact factor: 4.272

5.  SpDamID: Marking DNA Bound by Protein Complexes Identifies Notch-Dimer Responsive Enhancers.

Authors:  Matthew R Hass; Hien-Haw Liow; Xiaoting Chen; Ankur Sharma; Yukiko U Inoue; Takayoshi Inoue; Ashley Reeb; Andrew Martens; Mary Fulbright; Saravanan Raju; Michael Stevens; Scott Boyle; Joo-Seop Park; Matthew T Weirauch; Michael R Brent; Raphael Kopan
Journal:  Mol Cell       Date:  2015-08-06       Impact factor: 17.970

6.  Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron.

Authors:  Hui-Teng Cheng; Mijin Kim; M Todd Valerius; Kameswaran Surendran; Karin Schuster-Gossler; Achim Gossler; Andrew P McMahon; Raphael Kopan
Journal:  Development       Date:  2007-01-17       Impact factor: 6.868

7.  Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch.

Authors:  Olga Y Lubman; Ma Xenia G Ilagan; Raphael Kopan; Doug Barrick
Journal:  J Mol Biol       Date:  2006-10-03       Impact factor: 5.469

8.  High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.

Authors:  Yang Xi; Yu-Sang Li; He-Bin Tang
Journal:  Mol Cell Biochem       Date:  2012-11-16       Impact factor: 3.396

Review 9.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

10.  Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes.

Authors:  Linda M Persson; Angus C Wilson
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.